Piramal Critical Care Patent-Cliff Exposure & CMS Drug Spending Portfolio

Piramal Critical Care (Bethlehem, PA): 1 reconciled FDA prescription therapies, $11.0M 2024 CMS Part D & Medicaid spend, and $251 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Headquarters / ClusterBethlehem, PA
Reconciled FDA Portfolio Therapies1
2025 to 2030 Patent-Cliff Revenue Exposure0.0%
Primary Portfolio LOE DateMulti-asset schedule
2024 CMS Total Public Spend$11.0M
2024 Medicare Part D Spend$131K
2024 Medicaid Spend$10.8M
California HCAI SB 17 FilingsSpecialty launch notice ($251 intro WAC)